Previous Close | 44.97 |
Open | 44.76 |
Bid | 0.00 x 3100 |
Ask | 0.00 x 1100 |
Day's Range | 44.29 - 44.92 |
52 Week Range | 37.80 - 46.97 |
Volume | |
Avg. Volume | 5,268,265 |
Market Cap | 112.915B |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | 17.56 |
EPS (TTM) | 2.53 |
Earnings Date | Feb 01, 2017 - Feb 06, 2017 |
Forward Dividend & Yield | 1.99 (4.42%) |
Ex-Dividend Date | May 19, 2022 |
1y Target Est | 49.81 |
Subscribe to Yahoo Finance Plus to view Fair Value for GSK
GSK majority-owned company in talks with regulators on generic manufacture of highly effective PrEP injection
Innoviva (INVA) is set to acquire Entasis (ETTX) for $2.20 per share in cash. The transaction is likely to close by third-quarter 2022.
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.